What is the procedure for using Negative Pressure Wound Therapy (NPWT) on split skin grafts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Negative Pressure Wound Therapy on Split Skin Grafts: Procedure

Apply NPWT directly over the split-thickness skin graft at 75-125 mm Hg continuous negative pressure for 4-5 days postoperatively to secure the graft and optimize take rates.

Technical Setup and Application

Graft Preparation and NPWT Assembly

  • Place a non-adherent interface dressing directly on the freshly applied split-thickness skin graft to prevent foam adherence and minimize trauma during removal 1, 2.
  • Apply NPWT foam over the interface layer, ensuring complete coverage of the grafted area 2.
  • Seal the entire assembly with an occlusive adhesive drape, creating an airtight seal 3.
  • Suture or staple fixation of the graft is optional when using NPWT, as the negative pressure itself provides adequate graft stabilization and prevents shearing 2.

Pressure Settings and Duration

  • Set continuous negative pressure at 75-125 mm Hg depending on patient tolerance and wound characteristics 1, 4.
    • Lower pressures (75-80 mm Hg) reduce pain while maintaining efficacy, particularly beneficial for patients with complex wounds or multiple comorbidities 1, 4.
    • Standard pressure (125 mm Hg) can be used but may increase discomfort during therapy 1.
  • Maintain NPWT continuously for 4-5 days postoperatively before the first dressing change and graft assessment 3, 4.

Mechanism of Action

  • NPWT promotes graft adherence by removing fluid accumulation (seroma/hematoma) between the graft and recipient bed 5.
  • Enhances microcirculation at the graft-bed interface, facilitating neovascularization 5.
  • Provides uniform pressure distribution that immobilizes the graft and prevents shearing forces 2.

Expected Outcomes and Assessment

  • Expect 95-97% graft take rates at day 4-5 when NPWT is properly applied 3, 2, 4.
  • At the first dressing change (postoperative day 4-5), measure adherent versus non-adherent graft areas to assess take percentage 3.
  • Complete healing typically occurs within 5-8 days with NPWT, compared to 9-11 days with conventional dressings 5, 4.

Cost-Effective Alternative

  • A gauze-based system using standard surgical gauze, occlusive dressing, and wall suction produces equivalent results to commercial VAC devices at significantly lower cost 3.
  • This approach achieves 96% graft take, identical to proprietary NPWT systems 3.

Clinical Advantages Over Conventional Dressing

  • Eliminates need for multiple dressing changes during the critical first 4-5 days 4.
  • Reduces operative time by approximately 24 minutes when sutures are omitted 2.
  • Decreases pain associated with suture removal and frequent dressing changes 1, 2.
  • Particularly valuable for less-than-ideal wound beds, complex wounds, or patients with comorbidities 1, 4.

Common Pitfalls to Avoid

  • Do not use NPWT foam directly on the graft without an interface layer, as this causes significant trauma and graft loss during removal 1, 2.
  • Avoid pressure settings above 125 mm Hg, which increase pain without improving outcomes 1.
  • Ensure complete seal of the occlusive dressing; air leaks compromise the negative pressure and reduce efficacy 3.
  • Do not discontinue NPWT before 4 days unless infection or other complications develop, as premature removal reduces graft take 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.